Workflow
Altria(MO) - 2025 Q1 - Quarterly Results
MOAltria(MO)2025-04-29 11:03

Financial Performance - Altria reported Q1 2025 net revenues of 5,259million,adecreaseof5.75,259 million, a decrease of 5.7% compared to Q1 2024[3]. - Adjusted diluted EPS for Q1 2025 increased by 6.0% to 1.23, while reported diluted EPS decreased by 47.9% to 0.63[3][23].−NetrevenuesforQ12025were0.63[3][23]. - Net revenues for Q1 2025 were 5,259 million, a decrease of 5.7% compared to 5,576millioninQ12024[63].−GrossprofitforQ12025was5,576 million in Q1 2024[63]. - Gross profit for Q1 2025 was 3,249 million, down 0.9% from 3,280millioninQ12024[63].−NetearningsforQ12025were3,280 million in Q1 2024[63]. - Net earnings for Q1 2025 were 1,077 million, representing a significant decline of 49.4% from 2,129millioninQ12024[70].−Dilutedearningspershare(EPS)forQ12025were2,129 million in Q1 2024[70]. - Diluted earnings per share (EPS) for Q1 2025 were 0.63, a decrease of 47.9% compared to 1.21inQ12024[70].−OperatingcompaniesincomeforQ12025was1.21 in Q1 2024[70]. - Operating companies income for Q1 2025 was 1,888 million, down 32.9% from 2,813millioninQ12024[63].−Thecompanyincurredacquisition−relatedexpensesof2,813 million in Q1 2024[63]. - The company incurred acquisition-related expenses of 34 million and asset impairment costs of 873millioninQ12025[78].SegmentPerformance−Thesmokeableproductssegmentsawa13.7873 million in Q1 2025[78]. Segment Performance - The smokeable products segment saw a 13.7% decrease in domestic cigarette shipment volume, attributed to industry decline and retail share losses[37]. - Total smokeable products shipment volume decreased by 13.4% to 14,609 million sticks in Q1 2025 from 16,867 million sticks in Q1 2024[39]. - Smokeable products generated net revenues of 4,622 million in Q1 2025, a decrease of 5.8% from 4,906millioninQ12024[65].−Netrevenuesfororaltobaccoproductsincreasedby0.54,906 million in Q1 2024[65]. - Net revenues for oral tobacco products increased by 0.5% to 654 million in Q1 2025 from 651millioninQ12024[44].−ReportedOCIfororaltobaccoproductsdecreasedby0.5651 million in Q1 2024[44]. - Reported OCI for oral tobacco products decreased by 0.5% to 433 million in Q1 2025 from 435millioninQ12024[44].−Totaloraltobaccoproductsshipmentvolumedecreasedby5.0435 million in Q1 2024[44]. - Total oral tobacco products shipment volume decreased by 5.0% to 175.4 million cans in Q1 2025 from 184.6 million cans in Q1 2024[46]. - The oral tobacco products segment's shipment volume decreased by an estimated 1% when adjusted for calendar differences and trade inventory movements[48]. Market Share and Retail Performance - Marlboro's retail share of total cigarettes declined by 1.0 percentage points to 41.0% in Q1 2025 compared to 42.0% in Q1 2024[40]. - Copenhagen's retail share decreased by 3.2 percentage points to 16.9% in Q1 2025 compared to 20.1% in Q1 2024[50]. - The U.S. nicotine pouch category grew to 49.1% of the U.S. oral tobacco category, an increase of 8.7 percentage points versus the prior year[51]. - The total cigarette industry discount retail share increased by 1.8 percentage points to 30.9% compared to the prior year[41]. - Overall, the company is experiencing a downward trend in retail shares for key products, indicating potential challenges in market performance[86]. Guidance and Future Outlook - The company expects full-year 2025 adjusted diluted EPS to be in the range of 5.30 to 5.45,reflectingagrowthrateof25.45, reflecting a growth rate of 2% to 5% from a base of 5.19 in 2024[12][14]. - Altria's guidance for 2025 considers the impact of increased tariffs and assumes limited effects from enforcement in the illicit e-vapor market[13][14]. - The company anticipates continued challenges in the credit and capital markets, which may impact future performance[61]. Asset and Liability Overview - Total assets increased to 35,760millionasofMarch31,2025,comparedto35,760 million as of March 31, 2025, compared to 35,177 million at the end of 2024[76]. - Total liabilities rose to 39,220million,upfrom39,220 million, up from 37,365 million at the end of 2024, with total debt increasing to 26,059million[76].−Cashandcashequivalentsincreasedsignificantlyto26,059 million[76]. - Cash and cash equivalents increased significantly to 4,726 million in Q1 2025, up from 3,127millionattheendof2024[76].−Thecompanyreportedatotalof3,127 million at the end of 2024[76]. - The company reported a total of 3,032 million in accrued settlement charges as of March 31, 2025, compared to 2,354millionattheendof2024[76].ImpairmentandCharges−Altriarecordedanon−cashimpairmentchargeof2,354 million at the end of 2024[76]. Impairment and Charges - Altria recorded a non-cash impairment charge of 873 million related to e-vapor reporting unit goodwill in Q1 2025[6][26]. - The company reported an impairment of goodwill amounting to 873millioninQ12025[63].−Thesegmentdetailofexcisetaxesonproductssoldwas873 million in Q1 2025[63]. - The segment detail of excise taxes on products sold was 740 million in Q1 2025, down from 859millioninQ12024[68].−Lossesfrominvestmentsinequitysecuritiestotaled859 million in Q1 2024[68]. - Losses from investments in equity securities totaled 143 million in Q1 2025, compared to losses of $295 million in Q1 2024[68].